Global Research Initiative for Patients Screening on MASH
Conditions
MASH · MASLD · MASH With Fibrosis · Fibrosis, Liver · Steatosis of Liver · Type 2 Diabetes · Obesity · Metabolic Syndrome · Arterial Hypertension
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hôpital Erasme, Cliniques Universitaires De Bruxelles, Brussels, Vlaams-brabant, Belgium
Antwerp University Hospital, Antwerp, Belgium
4th internal clinic General University Hospital, Prague, Bohemia, Czechia
Hôpital de la Pitié Salpêtrière, Paris, Il-de-France, France
Universitätsmedizin Mainz, Mainz, Rhineland-Palatinate, Germany
Universitätsklinikum des Saarlandes, Homburg, Saarland, Germany
Harokopio University of Athens, Athens, Greece
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (FPG), Università Cattolica del Sacro Cuore (UCSC), Rome, Lazio, Italy
Amsterdam UMC, Amsterdam, South Holland, Netherlands
Franciscus Gasthuis & Vlietland, Rotterdam, South Holland, Netherlands
ULSSM - Unidade Local de Saúde Santa Maria, E.P.E, Lisbon, Portugal
Sacele Municipal Hospital, Săcele, Brașov County, Romania
Hospital Universitario Virgen del Rocío, Seville, Spain
Study leads
Manuel Castro Cabezas, MD/PhD
Principal Investigator
Sint Franciscus Gasthuis
Diederick E. Grobbee, MD/PhD/FESC
Principal Investigator
UMC Utrecht
Oscar H. Franco, MD/PhD/FESC/FFPH
Study Chair
UMC Utrecht